Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia

NCT07585734 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped drug-associated adverse reactions

Conditions

T-ALL

Interventions

DRUG: Pediatric-Inspired Chemotherapy Regimen

Sponsor

Institute of Hematology & Blood Diseases Hospital, China